Hope is the Air We Breathe
New Guidelines for Early Diagnosis and Treatment of Lymphangioleiomyomatosis
Lymphangioleiomyomatosis - or LAM - is a rare lung disease that usually strikes women during the prime of their lives. With the release of new clinical guidelines comes better understanding for the appropriate treatment of this debilitating illness, for both healthcare providers and patients alike. With this greater understanding comes greater hope for a cure. Just as air is vital to life, guidelines for diagnosis and treatment are vital to those living with LAM – and to the physicians working to treat them.
The American Thoracic Society (ATS) and the Japanese Respiratory Society (JRS), in conjunction with an ad hoc guideline development committee of LAM experts, prepared the following guidelines for the treatment of lymphangioleiomyomatosis.
DOWNLOAD THE 2016 LAM CLINICAL PRACTICE GUIDELINES HERE.
DOWNLOAD THE 2017 LAM CLINICAL PRACTICE GUIDELINES HERE.
ATS/JRS LAM Clinical Practice Guidelinesplus